BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 27216153)

  • 21. Insulin like growth factor binding protein-7 reduces growth of human breast cancer cells and xenografted tumors.
    Amemiya Y; Yang W; Benatar T; Nofech-Mozes S; Yee A; Kahn H; Holloway C; Seth A
    Breast Cancer Res Treat; 2011 Apr; 126(2):373-84. PubMed ID: 20464481
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Baicalein suppresses metastasis of breast cancer cells by inhibiting EMT via downregulation of SATB1 and Wnt/β-catenin pathway.
    Ma X; Yan W; Dai Z; Gao X; Ma Y; Xu Q; Jiang J; Zhang S
    Drug Des Devel Ther; 2016; 10():1419-41. PubMed ID: 27143851
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Plumbagin Suppresses the Invasion of HER2-Overexpressing Breast Cancer Cells through Inhibition of IKKα-Mediated NF-κB Activation.
    Kawiak A; Domachowska A
    PLoS One; 2016; 11(10):e0164064. PubMed ID: 27727280
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MRTF-A and STAT3 promote MDA-MB-231 cell migration via hypermethylating BRSM1.
    Xing WJ; Liao XH; Wang N; Zhao DW; Zheng L; Zheng DL; Dong J; Zhang TC
    IUBMB Life; 2015 Mar; 67(3):202-17. PubMed ID: 25854163
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CITED2 modulates estrogen receptor transcriptional activity in breast cancer cells.
    Lau WM; Doucet M; Huang D; Weber KL; Kominsky SL
    Biochem Biophys Res Commun; 2013 Jul; 437(2):261-6. PubMed ID: 23811274
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Protein kinase C induces motility of breast cancers by upregulating secretion of urokinase-type plasminogen activator through activation of AP-1 and NF-kappaB.
    Sliva D; English D; Lyons D; Lloyd FP
    Biochem Biophys Res Commun; 2002 Jan; 290(1):552-7. PubMed ID: 11779207
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Negative feedback regulation of NF-κB action by CITED2 in the nucleus.
    Lou X; Sun S; Chen W; Zhou Y; Huang Y; Liu X; Shan Y; Wang C
    J Immunol; 2011 Jan; 186(1):539-48. PubMed ID: 21098220
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CITED2-mediated human hematopoietic stem cell maintenance is critical for acute myeloid leukemia.
    Korthuis PM; Berger G; Bakker B; Rozenveld-Geugien M; Jaques J; de Haan G; Schuringa JJ; Vellenga E; Schepers H
    Leukemia; 2015 Mar; 29(3):625-35. PubMed ID: 25184385
    [TBL] [Abstract][Full Text] [Related]  

  • 29. C-erbB-2/ HER-2 upregulates fascin, an actin-bundling protein associated with cell motility, in human breast cancer cell lines.
    Grothey A; Hashizume R; Ji H; Tubb BE; Patrick CW; Yu D; Mooney EE; McCrea PD
    Oncogene; 2000 Oct; 19(42):4864-75. PubMed ID: 11039904
    [TBL] [Abstract][Full Text] [Related]  

  • 30. RING1 and YY1 binding protein suppresses breast cancer growth and metastasis.
    Zhou H; Li J; Zhang Z; Ye R; Shao N; Cheang T; Wang S
    Int J Oncol; 2016 Dec; 49(6):2442-2452. PubMed ID: 27748911
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bioluminescent human breast cancer cell lines that permit rapid and sensitive in vivo detection of mammary tumors and multiple metastases in immune deficient mice.
    Jenkins DE; Hornig YS; Oei Y; Dusich J; Purchio T
    Breast Cancer Res; 2005; 7(4):R444-54. PubMed ID: 15987449
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Knockdown of Cbp/P300-interacting transactivator with Glu/Asp-rich carboxy-terminal domain 2 inhibits cell division and increases apoptosis in gastric cancer.
    Tang Z; He G; Xu J; Zhongfu L
    J Surg Res; 2017 May; 211():1-7. PubMed ID: 28501104
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Maximal adamantyl-substituted retinoid-related molecule-induced apoptosis requires NF-κB noncanonical and canonical pathway activation.
    Farhana L; Dawson MI; Murshed F; Fontana JA
    Cell Death Differ; 2011 Jan; 18(1):164-73. PubMed ID: 20671747
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epithelial requirement for in vitro proliferation and xenograft growth and metastasis of MDA-MB-468 human breast cancer cells: oncogenic rather than tumor-suppressive role of E-cadherin.
    Hugo HJ; Gunasinghe NPAD; Hollier BG; Tanaka T; Blick T; Toh A; Hill P; Gilles C; Waltham M; Thompson EW
    Breast Cancer Res; 2017 Jul; 19(1):86. PubMed ID: 28750639
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Curcumol Suppresses Breast Cancer Cell Metastasis by Inhibiting MMP-9 Via JNK1/2 and Akt-Dependent NF-κB Signaling Pathways.
    Ning L; Ma H; Jiang Z; Chen L; Li L; Chen Q; Qi H
    Integr Cancer Ther; 2016 Jun; 15(2):216-25. PubMed ID: 27125675
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gold clusters prevent breast cancer bone metastasis by suppressing tumor-induced osteoclastogenesis.
    Zhang Z; Yao Y; Yuan Q; Lu C; Zhang X; Yuan J; Hou K; Zhang C; Du Z; Gao X; Chen X
    Theranostics; 2020; 10(9):4042-4055. PubMed ID: 32226538
    [No Abstract]   [Full Text] [Related]  

  • 37. VEGF/NRP-1axis promotes progression of breast cancer via enhancement of epithelial-mesenchymal transition and activation of NF-κB and β-catenin.
    Luo M; Hou L; Li J; Shao S; Huang S; Meng D; Liu L; Feng L; Xia P; Qin T; Zhao X
    Cancer Lett; 2016 Apr; 373(1):1-11. PubMed ID: 26805761
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CITED2 silencing sensitizes cancer cells to cisplatin by inhibiting p53 trans-activation and chromatin relaxation on the ERCC1 DNA repair gene.
    Liu YC; Chang PY; Chao CC
    Nucleic Acids Res; 2015 Dec; 43(22):10760-81. PubMed ID: 26384430
    [TBL] [Abstract][Full Text] [Related]  

  • 39. TRIM44 Is a Poor Prognostic Factor for Breast Cancer Patients as a Modulator of NF-κB Signaling.
    Kawabata H; Azuma K; Ikeda K; Sugitani I; Kinowaki K; Fujii T; Osaki A; Saeki T; Horie-Inoue K; Inoue S
    Int J Mol Sci; 2017 Sep; 18(9):. PubMed ID: 28885545
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Metastasis-Associated Protein 2 Represses NF-κB to Reduce Lung Tumor Growth and Inflammation.
    El-Nikhely N; Karger A; Sarode P; Singh I; Weigert A; Wietelmann A; Stiewe T; Dammann R; Fink L; Grimminger F; Barreto G; Seeger W; Pullamsetti SS; Rapp UR; Savai R
    Cancer Res; 2020 Oct; 80(19):4199-4211. PubMed ID: 32816854
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.